Login

Palexia SR 250 mg prolonged-release tablets *

  • Company:

    Grunenthal Pharma Ltd.

  • Status:

    Updated

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

  • Active Ingredient(s):

    Tapentadol hydrochloride

    *Additional information is available within the SPC or upon request to the company

  • PALEXIA-SR-250MG-[Left].jpeg
  • undefined
  • undefined
  • undefined

  • What is a Patient Information leaflet and why is it useful?

    A Patient Information Leaflet (PIL) is the leaflet containing information on taking or using a medicine for patients, included with medicine packaging. It is written by pharmaceutical companies as a patient version of the Summary of Product Characteristics (SPC). Changes to the PIL after your medicine was packed may mean the version on medicines.ie may differ from the version found with your medicine.

  • What is an XPIL?

    Some pharmaceutical companies have chosen to display PIL in a HTML text only “Print View” version, called an XPIL, as well as in PDF format. The XPIL is designed for people who are blind or partially-sighted.

  • ie_uk-common-leaflet-Palexia SR combined strengths-approved v2-clean

    Last updated: 13/10/21